CATX
Perspective Therapeutics Inc.
NYSE MKT: CATX · HEALTHCARE · MEDICAL DEVICES
$3.90
-0.89% today
Updated 2026-04-30
Market cap
$514.22M
P/E ratio
—
P/S ratio
581.70x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$2 – $6
Volume
1.6M
Perspective Therapeutics Inc. (CATX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.61M | $4.61M | $4.77M | $4.77M | $4.76M | $4.76M | $5.92M | $7.31M | $7.31M | $9.68M | $9.68M | $10.05M | $10.05M | $10.79M | $10.79M | $7.10M | $7.10M | $1.43M | $0.00 | $0.00 |
| Revenue growth (YoY) | — | +0.0% | +3.5% | +0.0% | -0.2% | +0.0% | +24.4% | +23.5% | +0.0% | +32.3% | +0.0% | +3.9% | +0.0% | +7.4% | +0.0% | -34.2% | +0.0% | -79.8% | -100.0% | — |
| Cost of revenue | $4.44M | $4.44M | $4.64M | $4.64M | $3.92M | $3.92M | $4.08M | $4.27M | $4.27M | $4.56M | $4.56M | $4.93M | $4.93M | $6.18M | $6.18M | $5.47M | $5.47M | — | — | — |
| Gross profit | $167393.00 | $167393.00 | $129154.00 | $129154.00 | $838000.00 | $838000.00 | $1.84M | $3.05M | $3.05M | $5.12M | $5.12M | $5.12M | $5.12M | $4.62M | $4.62M | $1.63M | $1.63M | $1.43M | — | — |
| Gross margin | 3.6% | 3.6% | 2.7% | 2.7% | 17.6% | 17.6% | 31.1% | 41.7% | 41.7% | 52.9% | 52.9% | 50.9% | 50.9% | 42.8% | 42.8% | 23.0% | 23.0% | 100.0% | — | — |
| R&D | $614771.00 | $614771.00 | $528049.00 | $528049.00 | $965000.00 | $965000.00 | $1.75M | $1.47M | $1.47M | $1.13M | $1.13M | $1.43M | $1.43M | $2.58M | $2.58M | $2.60M | $2.60M | $21.31M | $41.64M | $84.22M |
| SG&A | $2.40M | $2.40M | $3.79M | $3.79M | $3.92M | $3.92M | $4.17M | $4.17M | $4.17M | $4.57M | $4.57M | $4.69M | $4.69M | $9.43M | $6.62M | $10.87M | $10.87M | $20.97M | $26.61M | $30.23M |
| Operating income | $-4.34M | $-4.34M | $-5.08M | $-5.08M | $-6.31M | $-6.31M | $-6.73M | $-5.28M | $-5.28M | $-3.48M | $-3.48M | $-3.44M | $-3.44M | $-7.39M | $-7.39M | $-15.18M | $-15.18M | $-40.94M | $10.46M | $9.14M |
| Operating margin | -94.1% | -94.1% | -106.6% | -106.6% | -132.5% | -132.5% | -113.6% | -72.2% | -72.2% | -35.9% | -35.9% | -34.2% | -34.2% | -68.5% | -68.5% | -213.7% | -213.7% | -2855.0% | — | — |
| EBITDA | $-4.05M | $-4.05M | $-4.39M | $-4.39M | $-6.19M | $-6.19M | $-6.70M | $-5.30M | $-5.30M | $-3.48M | $-3.33M | $-3.43M | $-3.43M | — | $-7.14M | $-14.84M | $-14.84M | $-39.96M | $10.46M | $9.14M |
| EBITDA margin | -88.0% | -88.0% | -92.1% | -92.1% | -130.0% | -130.0% | -113.1% | -72.5% | -72.5% | -35.9% | -34.4% | -34.1% | -34.1% | 0.0% | -66.2% | -208.9% | -208.9% | -2786.6% | — | — |
| EBIT | $-4.63M | $-4.63M | $-4.86M | $-4.86M | $-6.26M | $-6.26M | $-6.78M | $-5.28M | $-5.28M | $-3.62M | $-3.48M | $-3.44M | $-3.44M | — | $-7.39M | $-15.18M | $-15.18M | $-40.94M | — | $5.88M |
| Interest expense | $2214.00 | $2000.00 | $950.00 | $1000.00 | $145000.00 | $145000.00 | $29000.00 | $29000.00 | $134000.00 | — | $30000.00 | — | $50000.00 | — | $119000.00 | $119000.00 | — | $84000.00 | $48000.00 | $376000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-3.68M | $-3.68M | $-4.71M | $-4.71M | $-6.16M | $-6.16M | $-6.70M | $-4.85M | $-4.85M | $-3.27M | $-3.27M | $-3.19M | $-3.19M | $-7.27M | $-7.15M | $-14.67M | $-14.67M | $-46.51M | $-79.28M | $-103.12M |
| Net income growth (YoY) | — | +0.0% | -28.0% | +0.0% | -30.8% | +0.0% | -8.7% | +27.6% | +0.0% | +32.6% | +0.0% | +2.5% | +0.0% | -128.1% | +1.6% | -105.1% | +0.0% | -217.0% | -70.5% | -30.1% |
| Profit margin | -79.9% | -79.9% | -98.8% | -98.8% | -129.4% | -129.4% | -113.1% | -66.3% | -66.3% | -33.8% | -33.8% | -31.7% | -31.7% | -67.4% | -66.3% | -206.5% | -206.5% | -3243.2% | — | — |